Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.02 - $3.23 $4,271 - $13,527
-4,188 Reduced 38.27%
6,754 $8,000
Q4 2023

Feb 13, 2024

SELL
$1.72 - $3.18 $72,224 - $133,531
-41,991 Reduced 79.33%
10,942 $29,000
Q3 2023

Nov 14, 2023

SELL
$2.13 - $5.55 $14,622 - $38,100
-6,865 Reduced 11.48%
52,933 $120,000
Q2 2023

Aug 21, 2023

BUY
$3.6 - $5.25 $94,240 - $137,434
26,178 Added 77.86%
59,798 $260,000
Q1 2023

May 09, 2023

SELL
$4.3 - $8.27 $92,716 - $178,317
-21,562 Reduced 39.07%
33,620 $149,000
Q4 2022

Feb 14, 2023

BUY
$5.66 - $8.42 $312,330 - $464,632
55,182 New
55,182 $464,000
Q2 2022

Aug 15, 2022

SELL
$2.6 - $6.14 $111,035 - $262,214
-42,706 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.08 - $9.81 $20,182 - $38,975
-3,973 Reduced 8.51%
42,706 $243,000
Q4 2021

Feb 15, 2022

BUY
$8.55 - $111.89 $12,773 - $167,163
1,494 Added 3.31%
46,679 $457,000
Q3 2021

Nov 15, 2021

SELL
$76.53 - $110.43 $228,824 - $330,185
-2,990 Reduced 6.21%
45,185 $4.78 Million
Q2 2021

Aug 16, 2021

BUY
$85.37 - $114.1 $737,169 - $985,253
8,635 Added 21.84%
48,175 $4.11 Million
Q1 2021

May 18, 2021

SELL
$109.73 - $153.66 $20,409 - $28,580
-186 Reduced 0.47%
39,540 $4.54 Million
Q4 2020

Feb 16, 2021

BUY
$79.58 - $152.45 $227,678 - $436,159
2,861 Added 7.76%
39,726 $5.56 Million
Q3 2020

Nov 17, 2020

BUY
$66.43 - $90.99 $9,632 - $13,193
145 Added 0.39%
36,865 $3 Million
Q2 2020

Aug 17, 2020

BUY
$44.04 - $80.69 $313,652 - $574,674
7,122 Added 24.06%
36,720 $2.64 Million
Q1 2020

May 13, 2020

SELL
$44.49 - $93.39 $6,540 - $13,728
-147 Reduced 0.49%
29,598 $1.32 Million
Q4 2019

Feb 14, 2020

SELL
$66.49 - $137.73 $39,960 - $82,775
-601 Reduced 1.98%
29,745 $2.84 Million
Q3 2019

Nov 15, 2019

BUY
$31.0 - $89.73 $112,747 - $326,348
3,637 Added 13.62%
30,346 $2.39 Million
Q2 2019

Aug 14, 2019

BUY
$36.0 - $44.73 $169,128 - $210,141
4,698 Added 21.34%
26,709 $1.16 Million
Q1 2019

May 09, 2019

BUY
$33.79 - $51.99 $299,514 - $460,839
8,864 Added 67.42%
22,011 $891,000
Q4 2018

Feb 13, 2019

BUY
$31.59 - $62.65 $17,342 - $34,394
549 Added 4.36%
13,147 $687,000
Q3 2018

Nov 14, 2018

BUY
$31.25 - $47.64 $393,687 - $600,168
12,598 New
12,598 $567,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $89.8M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.